# Greywolf Therapeutics funding: rounds and investors > Greywolf Therapeutics has raised $144M across 5 rounds since 2019. Investors include Canaan, Andera Partners and Earlybird Venture Capital. Source: https://millionrounds.com/company/grey-wolf-therapeutics (Millionrounds; every figure on the page links to its filing or article) United Kingdom · [Series B startup](https://millionrounds.com/companies) # Who invested in *Greywolf Therapeutics* 5 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Funding summary Updated 26 Oct 2026 **$144M** raised across 5 rounds since 2019, from 5 sources **$14M** Series A **$4.9M** Round **$39M** Round **$36M** Series B **$50M** Series B - **Latest round:** Series B, $50M May 2024 - **Step-up i:** 1.4× - **Investors:** 4 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2019 2020 2021 2022 2023 2024 **$14M** Series A **$4.9M** Round **$39M** Round **$36M** Series B **$50M** Series B - **First round:** Series A, $14M - **Biggest round:** $50M - **Usual gap between rounds:** 16 months ## The rounds - **May 2024** Series B **$50M** *2 new* *2 returning* [Canaan](https://millionrounds.com/fund/canaan-partners) [Earlybird Venture Capital](https://millionrounds.com/fund/earlybird) [Oxford Science Enterprises](https://millionrounds.com/fund/oxford-science-enterprises) [Andera Partners](https://millionrounds.com/fund/andera-partners) Source recorded - **Jan 2023** Series B **$36M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet - **Dec 2021** Round **$39M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet - **Oct 2021** Round **$4.9M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet - **Feb 2019** Series A **$14M** *2 new* [Canaan](https://millionrounds.com/fund/canaan-partners) [Andera Partners](https://millionrounds.com/fund/andera-partners) Reported by Globenewswire ## Funding filed with regulators Greywolf Therapeutics filed 3 raises, $80M in all. Filings say how much was sold and to how many investors; they never name the investors. - Jan 2023 **$36M** UK share allotment - Dec 2021 **$39M** UK share allotment - Oct 2021 **$4.9M** UK share allotment ## Founders and team From Greywolf Therapeutics's own website: 2 founders, 7 on the team. **Peter Joyce** Chief Executive Officer & Co-founder **Tom McCarthy** Non-Executive Director & Co-founder - **Andy Page** Chief Business Officer - **Paul Stainer** Chief Operating Officer - **Tom Lillie** Chief Medical Officer - **James Dodson** Head of People - **Jo Hume** Head of Finance - **Dr Edwin Moses** Chair - **Thierry Hercend** Industry Expert Director ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series A** 2019 **Round** 2021 **Round** 2021 **Series B** 2023 **Series B** 2024 [Canaan](https://millionrounds.com/fund/canaan-partners) [Andera Partners](https://millionrounds.com/fund/andera-partners) [Earlybird Venture Capital](https://millionrounds.com/fund/earlybird) [Oxford Science Enterprises](https://millionrounds.com/fund/oxford-science-enterprises) ## Everyone who backed them [Canaan](https://millionrounds.com/fund/canaan-partners) VC firm **2** rounds [Andera Partners](https://millionrounds.com/fund/andera-partners) Private equity **2** rounds [Earlybird Venture Capital](https://millionrounds.com/fund/earlybird) VC firm **1** round [Oxford Science Enterprises](https://millionrounds.com/fund/oxford-science-enterprises) VC firm **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=grey-wolf-therapeutics). ## Quick answers about Greywolf Therapeutics ### Who invested in Greywolf Therapeutics? Greywolf Therapeutics's investors include Canaan, Andera Partners, Earlybird Venture Capital and Oxford Science Enterprises. ### How much has Greywolf Therapeutics raised? Greywolf Therapeutics has raised $144M across 5 rounds since 2019. ### When did Greywolf Therapeutics last raise? Greywolf Therapeutics's most recent round was a Series B of $50M in May 2024. ### What was Greywolf Therapeutics's biggest round? Its most recent round, $50M in May 2024, is also its largest on record. ### Who backed Greywolf Therapeutics first? Greywolf Therapeutics's first round on record, in Feb 2019, was backed by Canaan and Andera Partners. ### What stage is Greywolf Therapeutics at? Greywolf Therapeutics's latest named round is a Series B, in May 2024. ### Where is Greywolf Therapeutics based? Greywolf Therapeutics is based in the United Kingdom. ## Companies like Greywolf Therapeutics In the same sector, and raised in the last eighteen months. [**Coherence Neuro** $55M · Oct 2026](https://millionrounds.com/company/coherence-neuro)[**HydRegen** $12M · Oct 2026](https://millionrounds.com/company/hydregen)[**XRlabs** $8.4M · Oct 2026](https://millionrounds.com/company/xrlabs)[**OMass Therapeutics** $442M · Oct 2026](https://millionrounds.com/company/omass-therapeutics)[**CMR Surgical** $1.1B · Oct 2026](https://millionrounds.com/company/cmr-surgical)[**MintNeuro** $26M · Oct 2026](https://millionrounds.com/company/mintneuro) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app